JamesTaylorVIMD

Hematology • Washington, DC

Sickle Cell & Other Anemias

Director, Center for Sickle Cell Disease, Howard University ; Professor of Medicine and Microbiology, Howard University College of Medicine

Join to view full profile

Dr. Taylor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Taylor's full profile

Already have an account?

Office
2041 Georgia Ave NW
Washington, DC 20060
Phone+1 612-625-1110

Fax+1 202-865-5018

Summary

Dr. James Taylor specializes in Hematology in Washington, DC and is affiliated with Howard University Hospital. Since 2017, he has served as the Director of the Howard University Center for Sickle Cell Disease. He is a Professor of Medicine (Hematology/Oncology) and Microbiology at Howard University College of Medicine; and also an Adjunct Professor in Food and Nutrition Sciences at the University of Manitoba, Winnipeg, Canada. He received his medical degree from Medical College of Wisconsin and has been in practice 22 years. He specializes in sickle cell & other anemias and is experienced in pulmonary hypertension, sickle-cell anemia, general internal medicine, clinical research, and genetic analysis. He is also a faculty member for training MS and PhD students.

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1995 - 1998
Medical College of WisconsinClass of 1995

Certifications & Licensure

MD State Medical License 2001 - 2025
DC State Medical License 2016 - 2024
MO State Medical License 1997 - 2022
MN State Medical License 2016 - 2018
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

John Benjamin Nichols Award Medical Society of the District of Columbia, 2023
Humanitarian Award Queens Sickle Cell Action Network (QSCAN)/SCDAA, 2019

Clinical Trials

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia Start of enrollment: 2008 Feb 19
Completed
Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria Start of enrollment: 2006 Jun 15
Completed
Genetics and Pain Severity in Sickle Cell Disease Start of enrollment: 2012 Jun 17
Completed
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease Start of enrollment: 2015 Jun 17
Completed
Phase 3
Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease Start of enrollment: 2015 Dec 16
Terminated
Phase 3
A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases Start of enrollment: 2017 Apr 11
Completed
Phase 2
A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) Start of enrollment: 2017 Dec 22
Completed
Phase 2
Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease Start of enrollment: 2020 Feb 05
Completed
Phase 1
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) Start of enrollment: 2020 Feb 26
Recruiting
Phase 3
Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease Start of enrollment: 2021 Jun 18
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

133 citations
Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S
Aarti Agarwal, Aldiouma Guindo, Yacouba Cissoko, James G. Taylor, Drissa Coulibaly
Blood. 2000-10-01
65 citations
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia.
Kohei Hosokawa, Pawel Muranski, Xingmin Feng, Danielle M. Townsley, Baoying Liu
Journal of Immunology. 2016-02-15
15 citations
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
Carlton D Dampier, Marilyn Jo Telen, Ted Wun, R Clark Brown, Payal Desai
Blood. 2023-01-12

Abstracts/Posters

Single Nucleotide Polymorphisms in SAR1A Codon Regions Associated with Hydroxyurea Response in Sickle Cell Disease and Potentially Influenced in Mirnas Binding
James G. Taylor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Cures for Sickle Cell Disease Arrive After a Painful JourneySeptember 17th, 2024
Hematologists consider where new therapies fit in sickle cell treatment paradigmDecember 19th, 2023
Top DC doctor reacts to new sickle cell treatmentDecember 15th, 2023
Join now to see all

Professional Memberships

American Academy of Pediatrics - AAP
Fellow
American Society of Hematology - ASH
Member
American Pain Society - APS
Member

Other Languages

French

External Links

ORCIDhttps://orcid.org/0000-0002-4421-1809
Scopus profilehttps://www.scopus.com/authid/detail.uri?authorId=7405408594